Delmer Dee Raibourn III
@Avidity Partners Management Lp
Latest period2024 - Q3ReportedManaged Assets$1.96BTotal holdings81
Assets growth rate-16.7%Assets growth rate (2-Q avg)-20.41%Continuous growth in asset value0 quarters
Portfolio positions
This chart displays the top 10 holdings in Avidity Partners Management Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 81 positions.
Assets under management
The assets under management (AUM) of Avidity Partners Management Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.96B in assets, with a quarterly growth rate of -16.7% and a 2-quarter average growth rate of -20.41%. The portfolio is managed by Delmer Dee Raibourn III, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
ZTSZoetis Inc
| 0.71% | $13.872M 71,000 shares@ $195.38 avg price | New Position |
BMYBristol-myers Squibb Co
| 0.7% | $13.608M 263,000 shares@ $51.74 avg price | New Position |
CYBNCybin Inc
| 0.42% | $8.161M 918,000 shares@ $8.89 avg price | New Position |
DYNDyne Therapeutics Inc
| 0.31% | $5.927M 165,000 shares@ $35.92 avg price | New Position |
TMDXTransmedics Group Inc
| 0.23% | $4.333M 27,600 shares@ $157.0 avg price | New Position |
QUREUniqure Nv
| 0.17% | $3.321M 673,618 shares@ $4.94 avg price | New Position |
ANROAlto Neuroscience Inc
| 0.15% | $2.746M 240,000 shares@ $11.44 avg price | New Position |
TILInstil Bio Inc
| 0.1% | $1.959M 29,100 shares@ $67.32 avg price | New Position |
PRLDPrelude Therapeutics Inc
| 0.1% | $1.842M 890,000 shares@ $2.07 avg price | New Position |
BLUEBluebird Bio Inc
| 0.05% | $847,379 1.631M shares@ $0.52 avg price | New Position |